2020
Strategic Anti-SARS-CoV-2 Serology Testing in a Low Prevalence Setting: The COVID-19 Contact (CoCo) Study in Healthcare Professionals
G M N Behrens, A Cossmann, M V Stankov, B Schulte, H Streeck, R Förster, B Bosnjak, S Willenzon, A L Boeck, A Thu Tran, T Thiele, T Graalmann, M Z Kayser, A Zychlinsky Scharff, C Dopfer, A Horke, I Pink, T Witte, M Wetzke, D Ernst, A Jablonka, C Happle
Erschienen in
Infect Dis Ther: Volume 9, Issue 4
Abstract
Serology testing is explored for epidemiological research and to inform individuals after suspected infection. During the coronavirus disease 2019 (COVID-19) pandemic, frontline healthcare professionals (HCP) may be at particular risk for infection. No longitudinal data on functional seroconversion in HCP in regions with low COVID-19 prevalence and low pre-test probability exist.
In PubMed öffnen